Incyte INCY
NASDAQ INCY
$127.42 -0.58 (-0.45%)
As of: Sep 4, 2026 · 11:51 AM EDT

Incyte (INCY) Other Non Operating Income (2017 - 2026)

Incyte's (INCY) quarterly Other Non Operating Income came in at $6.3 million in Q2 2026, down 14.12% YoY from $7.3 million in Q2 2025, and up 126.21% on a QoQ basis from $2.8 million in Q1 2026.

Analysis

Incyte (INCY) Other Non Operating Income (2017 - 2026) Analysis & Trends

Incyte (INCY) has 10 years of Other Non Operating Income data on file, last reported at $6.3 million in Q2 2026.

  • Quarterly Other Non Operating Income fell 14.12% year-over-year to $6.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $18.8 million (down 14.53% YoY) and the FY2025 annual result came in at $25.1 million, up 96.03% from the prior year.
  • Other Non Operating Income improved to $6.3 million in Q2 2026, from $2.8 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $46.4 million in Q3 2023 to a low of -$108.0 million in Q4 2023.
  • A 5-year average of $3.4 million and a median of $5.3 million in 2024 frame the typical range for Other Non Operating Income.
  • The widest YoY moves for Other Non Operating Income: up 8073.95% in 2023, down 681.66% in 2023.
  • Tracing INCY's Other Non Operating Income over 5 years: stood at -$13.8 million in 2022, then tumbled by 681.66% to -$108.0 million in 2023, then jumped by 101.49% to $1.6 million in 2024, then jumped by 251.15% to $5.7 million in 2025, then gained by 10.79% to $6.3 million in 2026.
  • The last three Other Non Operating Income figures came in at $6.3 million (Q2 2026), $2.8 million (Q1 2026), and $5.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 140.21 Bn 132.36 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.04 Bn 78.05 Bn 3.93 Bn
3 Argenx Se 63.73 Bn 58.55 Bn 1.37 Bn
4 Moderna 57.59 Bn 52.46 Bn 52.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn -
6 BeOne Medicines 40.13 Bn 35.04 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.55 Bn 32.24 Bn 992.69 Mn
8 Royalty Pharma 28.60 Bn 27.77 Bn -
9 Insmed 27.70 Bn 26.54 Bn 358.27 Mn
10 Incyte 25.52 Bn 20.98 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.28 Mn
Mar 31, 2026 2.77 Mn
Dec 31, 2025 5.66 Mn
Sep 30, 2025 4.04 Mn
Jun 30, 2025 7.31 Mn
Mar 31, 2025 8.10 Mn
Dec 31, 2024 1.61 Mn
Sep 30, 2024 4.93 Mn
Jun 30, 2024 8.29 Mn
Mar 31, 2024 -2.03 Mn
Dec 31, 2023 -107.98 Mn
Sep 30, 2023 46.37 Mn
Jun 30, 2023 42.67 Mn
Mar 31, 2023 32.87 Mn
Dec 31, 2022 -13.81 Mn
Sep 30, 2022 11.51 Mn
Jun 30, 2022 522,000.00
Mar 31, 2022 1.26 Mn
Dec 31, 2021 5.72 Mn
Sep 30, 2021 1.95 Mn